Pharmacy Practice
Affordable Medicines
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
Specialty Pharmacy
January 14, 2022
Pharmacist Involvement in Antibody-Drug Conjugate Therapy
The 12 antibody-drug conjugates currently FDA approved to treat hematologic or solid malignancies are similar in structure and concept, but each has a unique indication and molecular target.
September 22, 2021
Specialty Psoriasis Therapies Often Too Costly for Many Medicare Patients
September 17, 2021
Pharmacists Prescribing Hormonal Contraceptives: A Status Update
August 12, 2021
The Pharmacist’s Role in Pediatric Poison Control
July 26, 2021
Contemporary Developments in MET-Selective Kinase Inhibitors in Advanced NSCLC
July 26, 2021
Summarizing the 2021 Updated GOLD Guidelines for COPD
July 26, 2021
Biologic Therapy for Eosinophilic Asthma
July 21, 2021
Contemporary Developments in MET-Selective Kinase Inhibitors in Advanced Non–Small-Cell Lung Cancer
July 21, 2021
Biologic Therapy for Eosinophilic Asthma
May 20, 2021
Researchers Look for Drugs That Keep HIV Latent
May 20, 2021
B-Cell Factor Possible Key to Hemophilia Immune Tolerance
May 14, 2021
Overview of TNF Inhibitors for Treating Inflammatory Bowel Disease
March 18, 2021
How Useful Is the URAC Pharmacy-Reported HCV Completion of Therapy Measure?
Load More
X
May 2022
In This Issue
Digital Magazine
Archives
Subscription
×
Full Image